Peptide Comparison

BPC-157 vs TB-500 (Thymosin Beta-4)

BPC-157 and TB-500 (Thymosin Beta-4) are the two most common regenerative peptides. They are frequently combined because they act through complementary mechanisms — BPC-157 is primarily cytoprotective and anti-inflammatory; TB-500 promotes cell migration and angiogenesis.

BPC-157

BPC-157 is a synthetic pentadecapeptide. See the TruthTides evidence library for graded study summaries, regulatory status, and citations.

BPC-157 Clinical Reference

TB-500 (Thymosin Beta-4)

TB-500 is a synthetic fragment of Thymosin Beta-4. See the TruthTides evidence library for graded study summaries and citations.

TB-500 (Thymosin Beta-4) Clinical Reference

Key Differences

Category

BPC-157

TB-500 (Thymosin Beta-4)

Origin

Synthetic pentadecapeptide derived from human gastric juice.

Synthetic fragment of Thymosin Beta-4.

Primary mechanism

Cytoprotective, anti-inflammatory, supports tendon/gut healing.

Cell migration, angiogenesis, tissue regeneration.

Evidence base

Robust preclinical; human trials ongoing.

Preclinical wound-healing and angiogenesis data.

FDA status

Not FDA-approved.

This comparison is informational and reflects content from TruthTides clinical reference documentation. It does not constitute medical advice. Only three peptides on TruthTides — semaglutide, tirzepatide, and tesamorelin — carry FDA approvals; many others are compounded or off-label. Consult a qualified physician before starting any peptide therapy.

Ask TruthSource AI

Which is right for me — BPC-157 or TB-500 (Thymosin Beta-4)?

Get a guardrailed, evidence-anchored answer based on your goals.

Open Reference Tool

Find a Doctor

Find a physician who prescribes BPC-157 or TB-500 (Thymosin Beta-4)

Filter our directory by peptide, location, and telehealth availability.

Open Physician Finder

Other Peptide Comparisons

Semaglutide vs Tirzepatide

Ipamorelin vs CJC-1295

Sermorelin vs Ipamorelin

Sermorelin vs Tesamorelin